PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography.

This paper reports the body distribution of block copolymers (made by controlled radical polymerization) with N-(2-hydroxypropyl)methacrylamide (HPMA) as hydrophilic block and lauryl methacrylate (LMA) as hydrophobic block. They form micellar aggregates in aqueous solution. For this study the hydrophilic/hydrophobic balance was varied by incorporation of differing amounts of poly(ethylene glycol) (PEG) side chains into the hydrophilic block, while keeping the degree of polymerization of both blocks constant. PEGylation reduced the size of the micellar aggregates (Rh=113 to 38 nm) and led to a minimum size of 7% PEG side chains. Polymers were labeled with the positron emitter (18)F, which enables to monitor their biodistribution pattern for up to 4h with high spatial resolution. These block copolymers were investigated in Sprague-Dawley rats bearing the Walker 256 mammary carcinoma in vivo. Organ/tumor uptake was quantified by ex vivo biodistribution as well as small animal positron emission tomography (PET). All polymers showed renal clearance with time. Their uptake in liver and spleen decreased with size of the aggregates. This made PEGylated polymers--which form smaller aggregates--attractive as they show a higher blood pool concentration. Within the studied polymers, the block copolymer of 7% PEGylation exhibited the most favorable organ distribution pattern, showing highest blood-circulation level as well as lowest hepatic and splenic uptake. Most remarkably, the in vivo results revealed a continuous increase in tumor accumulation with PEGylation (independent of the blood pool concentration)--starting from lowest tumor uptake for the pure block copolymer to highest enrichment with 11% PEG side chains. These findings emphasize the need for reliable (non-invasive) in vivo techniques revealing overall polymer distribution and helping to identify drug carrier systems for efficient therapy.

[1]  Ruth Duncan,et al.  Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. , 2009, Advanced drug delivery reviews.

[2]  Soumen Das,et al.  PEGylated Inorganic Nanoparticles , 2011 .

[3]  Eric D. Pressly,et al.  Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. , 2008, Biomacromolecules.

[4]  Fabian Kiessling,et al.  Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy , 2010 .

[5]  K. Ulbrich,et al.  Detection and cellular localisation of the synthetic soluble macromolecular drug carrier pHPMA , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  G. Maurer,et al.  Osmotic Virial Coefficients of Aqueous Poly(ethylene glycol) from Laser-Light Scattering and Isopiestic Measurements , 1995 .

[7]  Oliver Thews,et al.  Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. , 2009, Biomacromolecules.

[8]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[9]  G. Pasut,et al.  Polymer-drug conjugation, recent achievements and general strategies , 2007 .

[10]  K. Ulbrich,et al.  Structural and chemical aspects of HPMA copolymers as drug carriers. , 2010, Advanced drug delivery reviews.

[11]  Zheng-Rong Lu.  Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. , 2010, Advanced drug delivery reviews.

[12]  D. Nowotnik,et al.  ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic. , 2009, Advanced drug delivery reviews.

[13]  K. Ulbrich,et al.  Preclinical evaluation of polymer-bound doxorubicin , 1992 .

[14]  R. Zentel,et al.  From defined reactive diblock copolymers to functional HPMA-based self-assembled nanoaggregates. , 2008, Biomacromolecules.

[15]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[16]  J. Kopeček,et al.  HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[17]  K. Ulbrich,et al.  Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. , 1994, Journal of drug targeting.

[18]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[19]  Wang Wen-ying.  Reversible Addition Fragmentation Chain-Transfer Polymerization , 2006 .

[20]  Harm-Anton Klok,et al.  Synthesis of functional polymers by post-polymerization modification. , 2009, Angewandte Chemie.

[21]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[22]  Gianfranco Pasut,et al.  PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.

[23]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[24]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[25]  Todd Emrick,et al.  PEGylated polymers for medicine: from conjugation to self-assembled systems. , 2010, Chemical communications.

[26]  J. Chiefari,et al.  Living free-radical polymerization by reversible addition - Fragmentation chain transfer: The RAFT process , 1998 .

[27]  O. Thews,et al.  Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation. , 2011, Biomacromolecules.

[28]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[29]  K. Blank,et al.  Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[30]  R. Zentel,et al.  Aggregation behavior of amphiphilic p(HPMA)-co-p(LMA) copolymers studied by FCS and EPR spectroscopy. , 2012, Biomacromolecules.

[31]  F. Rösch,et al.  72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging. , 2010, Bioorganic & medicinal chemistry letters.

[32]  P. Wakeley,et al.  Synthesis , 2013, The Role of Animals in Emerging Viral Diseases.

[33]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[34]  Patrick Theato,et al.  Synthesis of well‐defined polymeric activated esters , 2008 .

[35]  R. Zentel,et al.  Synthesis of pentafluorophenyl(meth)acrylate polymers: New precursor polymers for the synthesis of multifunctional materials , 2005 .

[36]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[37]  Thomas D. Dziubla,et al.  PEGylation of nanocarrier drug delivery systems: State of the art , 2008 .

[38]  Hisataka Kobayashi,et al.  Biologically optimized nanosized molecules and particles: more than just size. , 2011, Bioconjugate chemistry.

[39]  K. Matyjaszewski,et al.  Atom transfer radical polymerization. , 2001, Chemical reviews.

[40]  J. L. Turner,et al.  An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. , 2005, Biomacromolecules.

[41]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[42]  Chun Li,et al.  Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. , 2007, Biomacromolecules.

[43]  Ande Bao,et al.  In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. , 2010, International journal of pharmaceutics.

[44]  F. Rösch,et al.  HPMA based amphiphilic copolymers mediate central nervous effects of domperidone. , 2011, Macromolecular rapid communications.

[45]  Xiaoping Xu,et al.  Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates. , 2010, Journal of medicinal chemistry.

[46]  C. van Nostrum,et al.  Micelles based on HPMA copolymers. , 2010, Advanced drug delivery reviews.

[47]  Bryan Hoang,et al.  Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging. , 2009, Molecular pharmaceutics.

[48]  J. Kopeček,et al.  Effect of side-chains on solution properties of N-(2-hydroxypropyl)methacrylamide copolymers in aqueous solvents , 1993 .

[49]  Marie-Hélène Dufresne,et al.  Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[50]  O. Thews,et al.  HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution. , 2013, Biomacromolecules.

[51]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[52]  C. McCormick,et al.  Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media. , 2005, Biomacromolecules.

[53]  Andreas M. Nyström,et al.  Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. , 2008, Biomacromolecules.

[54]  Graeme Moad,et al.  Living Radical Polymerization by the RAFT Process , 2005 .

[55]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[56]  R. Zentel,et al.  The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells. , 2009, Biomaterials.